Compound Summary
urolithin B
Compound Information
urolithin B
Compound Name: | urolithin B |
Compound CID: | 5380406 |
Synonyms: | urolithin B 1139-83-9 3-hydroxy-6H-benzocchromen-6-one 3-hydroxybenzocchromen-6-one 3-HYDROXY-6H-DIBENZOB,DPYRAN-6-ONE More... |
Iupac Name: | 3-hydroxybenzo[c]chromen-6-one |
InChI: | InChI=1S/C13H8O3/c14-8-5-6-10-9-3-1-2-4-11(9)13(15)16-12(10)7-8/h1-7,14H |
InChIKey: | WXUQMTRHPNOXBV-UHFFFAOYSA-N |
Canonical Smiles: | C1=CC=C2C(=C1)C3=C(C=C(C=C3)O)OC2=O |
Isomeric Smiles: | C1=CC=C2C(=C1)C3=C(C=C(C=C3)O)OC2=O |
Molecular Weight: | 212.2 |
Molecular Formula: | C13H8O3 |
Compound Structure
2D Structure:
3D Structure:
Computed Properties
urolithin B
Molecular Weight: | 212.2 |
Molecular Formula: | C13H8O3 |
Hydrogen Bond Donor Count: | 1 |
Hydrogen Bond Acceptor Count: | 3 |
Rotatable Bond Count: | 0 |
Heavy Atom Count: | 16 |
Complexity: | 289 |
Synonyms
urolithin B
| urolithin B | urolithin B |
|---|---|
urolithin B |
1139-83-9 |
3-hydroxy-6H-benzocchromen-6-one |
3-hydroxybenzocchromen-6-one |
3-HYDROXY-6H-DIBENZOB,DPYRAN-6-ONE |
UNII-B1S2YM5F6G |
B1S2YM5F6G |
7-hydroxy-3,4-benzocoumarin |
6H-Dibenzob,dpyran-6-one, 3-hydroxy- |
CHEMBL1526978 |
3-Hydroxy-benzocchromen-6-one |
MFCD00034338 |
6H-Dibenzo(b,d)pyran-6-one, 3-hydroxy- |
SMR000125059 |
3-Hydroxyurolithin |
NSC94726 |
3-hydroxy-urolithin |
NSC 94726 |
3-Hydroxydibenzo-a-pyrone |
NCIOpen2_005982 |
Oprea1_202205 |
Oprea1_232259 |
CBDivE_012154 |
MLS000067644 |
MLS001049038 |
SCHEMBL4420540 |
3-hydroxy-6-benzocchromenone |
ZINC86978 |
DTXSID00150610 |
CHEBI:166606 |
HMS2172E20 |
HMS3319J06 |
NP755 |
Urolithin B, >=95% (HPLC) |
ALBB-015663 |
9156AC |
BBL027918 |
BDBM50521706 |
NSC-94726 |
s1321 |
SBB015144 |
STK086550 |
AKOS000274161 |
DS-9071 |
MCULE-9038476232 |
NCGC00245498-01 |
NCGC00245498-02 |
AC-34553 |
DB-122720 |
HY-126307 |
CS-0101847 |
FT-0778245 |
ST45027155 |
3-Hydroxy-6H-benzocchromen-6-one, AldrichCPR |
A920658 |
J-003044 |
Q18395107 |
Experimental Data
urolithin B
| Species | Dose | Unit | Control(Avg days) | Treatment(Avg days) | Avg/Med Lifespan Change(%) | Control(Max days) | Treatment(Max days) | Max Lifespan Change(%) | Significant | Strain | Gender | PubMed | Avg/Med Lifespan Change tab |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Caenorhabditis elegans | 50.000000000000000 | umol/L | 36.600000000000000 | S | N2 | 33683565 | Active | ||||||
| Caenorhabditis elegans | 50.000000000000000 | umol/L | 36.600000000000000 | S | N2 | 27400265 | Active |
Experimental Data Visualization
urolithin B
Statistics Data
urolithin B
| Species | Avg/Med Lifespan Change(%) | Max Lifespan Change(%) | Count Reference | Count Data point |
|---|---|---|---|---|
| Caenorhabditis elegans | 36.600000000000000 | 2 | 2 |
Statistics Data Visualization
urolithin B
